The clinical progress of mRNA vaccines and immunotherapies

2022/05/09 by Ann Barbier, Ann J. Barbier, Allen Yujie Jiang +3 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #RNA Interference and Gene Delivery #SARS-CoV-2 and COVID-19 Research #Virus-based gene therapy research

paper · pdf · doi:10.1038/s41587-022-01294-2

crossref issued 2022/05/09 · crossref published 2022/05/09 · crossref published-online 2022/05/09 · openalex publication_date 2022/05/09 · crossref created 2022/05/09 · crossref published-print 2022/06/01 · crossref deposited 2023/02/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04 · crossref indexed 2026/08/04

Citations

• mRNA-based therapeutics — developing a new class of drugs
• mRNA vaccines — a new era in vaccinology
• Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
• Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
• Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
• An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
• An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
• Addressing the Cold Reality of mRNA Vaccine Stability
• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
• Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
• CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Cited by

• Messenger RNA [wikipedia]